Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

NCT05626504 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-03-05

No results posted yet for this study

Summary

In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms

Conditions

  • Brain Aneurysm
  • Intracranial Hemorrhages
  • Stroke

Interventions

DEVICE

Pipeline Embolization Device with Vantage Technology

Flow-diverter device occludes aneurysms through endoluminal reconstruction and remodelling of the parent artery.

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-27
Primary Completion
2025-03-01
Completion
2025-03-31
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05626504 on ClinicalTrials.gov